Article

Biological effects of PPCPs on aquatic lives and evaluation of river waters affected by different wastewater treatment levels

Water Environment Research Group, Public Works Research Institute, 1-6, Minamihara, Tsukuba, Ibaraki Prefecture 305-8516, Japan.
Water Science & Technology (Impact Factor: 1.21). 02/2008; 58(8):1541-6. DOI: 10.2166/wst.2008.742
Source: PubMed

ABSTRACT The existence of pharmaceuticals and personal care products (PPCPs) in the water environment is an emerging problem. In this study, we investigated the toxicity of eleven PPCPs through bioassays on bacteria, algae, crustaceans, amphibians and protozoa, and compared the toxicology indexes with the concentration of PPCPs in river water for ecotoxiclogical risk evaluation. Toxicity of the eleven PPCPs was observed and the values of EC50 or LC50 were in the order of mg/L. A distinctive finding is that antibacterial triclosan affected all aquatic lives tested. The effects of PPCPs varied according to species of lives. Contamination from PPCPs was detected at observation stations on the river, and the range of concentration was in the order of ng/L far lower than the values of toxicity indexes EC50 or LC50. Ecotoxicological risks posed by PPCPs at the observation stations was evaluated using the concentration in the river water and the NOEC examined by AGI tests. The results revealed that three PPCPs, triclosan, clarithromycin, and azithromycin, posed an ecotoxiclogical risk in rivers where wastewater treatment systems are not yet well developed.

3 Followers
 · 
173 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pharmaceuticals and iodinated contrast media in a hospital waste-water: A case study to analyse their presence and characterise their environmental risk and hazard a b s t r a c t This work analyses the presence of twenty-five pharmaceutical compounds belonging to seven different therapeutic groups and one iodinated contrast media (ICM) in a Spanish medium-size hospital located in the Valencia Region. Analysis of the target compounds in the hospital wastewater was performed by means of solid phase extraction (SPE) followed by liquid chromatography-tandem mass spectrometry analysis (HPLC-MS/MS). A screening level risk assessment combining the measured environmental concentrations (MECs) with dose-response data based on Predicted No Effect Concentration (PNEC) was also applied to estimate Hazard Quotients (HQs) for the compounds investigated. Additionally, the environmental hazard associated to the various compounds measured was assessed through the calculation of the Persistence, Bioaccumulation and Toxicity (PBT) Index, which categorizes compounds according to their environmentally damaging characteristics. The results of the study showed the presence of twenty-four out of the twenty-six compounds analysed at individual concentrations ranging from 5 ng L À 1 to 2 mg L À 1. The highest concentrations corresponded to the ICM iomeprol, found at levels between 424 and 2093 μg L À 1 , the analgesic acetaminophen (15–44 μg L À 1), the diuretic (DIU) furosemide (6–15 μg L À 1), and the antibiotics (ABIs) ofloxacin and trimethoprim (2–5 μg L À 1). The lowest levels corresponded to the anti-inflammatory propyphenazone, found at concentrations between 5 and 44 ng L À 1. Differences in terms of concentrations of the analysed compounds have been observed in all the therapeutic groups when comparing the results obtained in this and other recent studies carried out in hospitals with different characteristics from different geographical areas and in different seasons. The screening level risk assessment performed in raw water from the hospital effluent showed that the analgesics and anti-inflammatories (AAFs) acetaminophen, diclofenac, ibuprofen and naproxen, the antibiotics (ABIs) clarithromycin, ofloxacin and trimethoprim, and the β-blocker (BBL) propranolol were present at concentrations leading to HQ values higher than 10, thus indicating high risk. When applying a
    Environmental Research 04/2015; · 3.95 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pharmaceuticals and iodinated contrast media in a hospital waste-water: A case study to analyse their presence and characterise their environmental risk and hazard a b s t r a c t This work analyses the presence of twenty-five pharmaceutical compounds belonging to seven different therapeutic groups and one iodinated contrast media (ICM) in a Spanish medium-size hospital located in the Valencia Region. Analysis of the target compounds in the hospital wastewater was performed by means of solid phase extraction (SPE) followed by liquid chromatography-tandem mass spectrometry analysis (HPLC-MS/MS). A screening level risk assessment combining the measured environmental concentrations (MECs) with dose-response data based on Predicted No Effect Concentration (PNEC) was also applied to estimate Hazard Quotients (HQs) for the compounds investigated. Additionally, the environmental hazard associated to the various compounds measured was assessed through the calculation of the Persistence, Bioaccumulation and Toxicity (PBT) Index, which categorizes compounds according to their environmentally damaging characteristics. The results of the study showed the presence of twenty-four out of the twenty-six compounds analysed at individual concentrations ranging from 5 ng L À 1 to 2 mg L À 1. The highest concentrations corresponded to the ICM iomeprol, found at levels between 424 and 2093 μg L À 1 , the analgesic acetaminophen (15–44 μg L À 1), the diuretic (DIU) furosemide (6–15 μg L À 1), and the antibiotics (ABIs) ofloxacin and trimethoprim (2–5 μg L À 1). The lowest levels corresponded to the anti-inflammatory propyphenazone, found at concentrations between 5 and 44 ng L À 1. Differences in terms of concentrations of the analysed compounds have been observed in all the therapeutic groups when comparing the results obtained in this and other recent studies carried out in hospitals with different characteristics from different geographical areas and in different seasons. The screening level risk assessment performed in raw water from the hospital effluent showed that the analgesics and anti-inflammatories (AAFs) acetaminophen, diclofenac, ibuprofen and naproxen, the antibiotics (ABIs) clarithromycin, ofloxacin and trimethoprim, and the β-blocker (BBL) propranolol were present at concentrations leading to HQ values higher than 10, thus indicating high risk. When applying a
    Environmental Research 04/2015; · 3.95 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pharmaceuticals and iodinated contrast media in a hospital waste-water: A case study to analyse their presence and characterise their environmental risk and hazard a b s t r a c t This work analyses the presence of twenty-five pharmaceutical compounds belonging to seven different therapeutic groups and one iodinated contrast media (ICM) in a Spanish medium-size hospital located in the Valencia Region. Analysis of the target compounds in the hospital wastewater was performed by means of solid phase extraction (SPE) followed by liquid chromatography-tandem mass spectrometry analysis (HPLC-MS/MS). A screening level risk assessment combining the measured environmental concentrations (MECs) with dose-response data based on Predicted No Effect Concentration (PNEC) was also applied to estimate Hazard Quotients (HQs) for the compounds investigated. Additionally, the environmental hazard associated to the various compounds measured was assessed through the calculation of the Persistence, Bioaccumulation and Toxicity (PBT) Index, which categorizes compounds according to their environmentally damaging characteristics. The results of the study showed the presence of twenty-four out of the twenty-six compounds analysed at individual concentrations ranging from 5 ng L À 1 to 2 mg L À 1. The highest concentrations corresponded to the ICM iomeprol, found at levels between 424 and 2093 μg L À 1 , the analgesic acetaminophen (15–44 μg L À 1), the diuretic (DIU) furosemide (6–15 μg L À 1), and the antibiotics (ABIs) ofloxacin and trimethoprim (2–5 μg L À 1). The lowest levels corresponded to the anti-inflammatory propyphenazone, found at concentrations between 5 and 44 ng L À 1. Differences in terms of concentrations of the analysed compounds have been observed in all the therapeutic groups when comparing the results obtained in this and other recent studies carried out in hospitals with different characteristics from different geographical areas and in different seasons. The screening level risk assessment performed in raw water from the hospital effluent showed that the analgesics and anti-inflammatories (AAFs) acetaminophen, diclofenac, ibuprofen and naproxen, the antibiotics (ABIs) clarithromycin, ofloxacin and trimethoprim, and the β-blocker (BBL) propranolol were present at concentrations leading to HQ values higher than 10, thus indicating high risk. When applying a